MediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement with BioNTech, expanding their global strategic partnership

SUZHOU, China, May 26, 2024 /PRNewswire/ -- MediLink Therapeutics Co., Ltd. , a clinical-stage biotech company, today announces a new strategic collaboration with BioNTech SE , a next-generation...

Related Keywords

Boston ,Massachusetts ,United States ,Shanghai ,China ,Macau ,Taiwan ,Suzhou ,Jiangsu , ,Prnewswire Medilink Therapeutics Suzhou Co Ltd ,Link Therapeutics ,Mainland China ,Hong Kong Special Administrative Region ,Medilink Therapeutics ,